{
 "drug": "Pemetrexed Disodium Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/10/2025",
 "dayN": 319,
 "cat": "Oncology",
 "companies": [
  "Sandoz Inc.",
  "Eli Lilly and Co."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/10/2025",
   "update_type": "New",
   "initial_posting_date": "10/10/2025",
   "package_ndc": "0781-3518-76",
   "generic_name": "Pemetrexed Disodium Injection",
   "contact_info": "800-525-8747",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA214657"
    ],
    "brand_name": [
     "PEMETREXED"
    ],
    "generic_name": [
     "PEMETREXED DISODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3518",
     "0781-3519",
     "0781-3520"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PEMETREXED DISODIUM"
    ],
    "rxcui": [
     "2602363",
     "2602365",
     "2602366"
    ],
    "spl_id": [
     "764ab64b-c642-4314-83a9-efee79fe83a3"
    ],
    "spl_set_id": [
     "7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3"
    ],
    "package_ndc": [
     "0781-3518-76",
     "0781-3519-90",
     "0781-3520-91"
    ],
    "unii": [
     "2PKU919BA9"
    ]
   },
   "update_date": "10/10/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76)",
   "company_name": "Sandoz Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/10/2025",
   "update_type": "New",
   "initial_posting_date": "10/10/2025",
   "package_ndc": "0781-3519-90",
   "generic_name": "Pemetrexed Disodium Injection",
   "contact_info": "800-525-8747",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA214657"
    ],
    "brand_name": [
     "PEMETREXED"
    ],
    "generic_name": [
     "PEMETREXED DISODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3519",
     "0781-3518",
     "0781-3520"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PEMETREXED DISODIUM"
    ],
    "rxcui": [
     "2602363",
     "2602365",
     "2602366"
    ],
    "spl_id": [
     "764ab64b-c642-4314-83a9-efee79fe83a3"
    ],
    "spl_set_id": [
     "7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3"
    ],
    "package_ndc": [
     "0781-3518-76",
     "0781-3519-90",
     "0781-3520-91"
    ],
    "unii": [
     "2PKU919BA9"
    ]
   },
   "update_date": "10/10/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90)",
   "company_name": "Sandoz Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/16/2025",
   "update_type": "New",
   "initial_posting_date": "10/16/2025",
   "package_ndc": "0002-7623-01",
   "generic_name": "Pemetrexed Disodium Injection",
   "contact_info": "800-545-5979",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA021462"
    ],
    "brand_name": [
     "ALIMTA"
    ],
    "generic_name": [
     "PEMETREXED DISODIUM"
    ],
    "manufacturer_name": [
     "Eli Lilly and Company"
    ],
    "product_ndc": [
     "0002-7623",
     "0002-7640"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PEMETREXED DISODIUM HEPTAHYDRATE"
    ],
    "rxcui": [
     "1728072",
     "1728075",
     "1728077",
     "1728079"
    ],
    "spl_id": [
     "3af0bc84-13d6-46aa-a4c0-c62410b73bc6"
    ],
    "spl_set_id": [
     "f5a860f3-37ec-429c-ae04-9c88d7c55c08"
    ],
    "package_ndc": [
     "0002-7640-01",
     "0002-7623-01"
    ],
    "unii": [
     "9T47E4OM16"
    ]
   },
   "update_date": "10/16/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/16/2025",
   "update_type": "New",
   "initial_posting_date": "10/16/2025",
   "package_ndc": "0002-7640-01",
   "generic_name": "Pemetrexed Disodium Injection",
   "contact_info": "800-545-5979",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA021462"
    ],
    "brand_name": [
     "ALIMTA"
    ],
    "generic_name": [
     "PEMETREXED DISODIUM"
    ],
    "manufacturer_name": [
     "Eli Lilly and Company"
    ],
    "product_ndc": [
     "0002-7640",
     "0002-7623"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PEMETREXED DISODIUM HEPTAHYDRATE"
    ],
    "rxcui": [
     "1728072",
     "1728075",
     "1728077",
     "1728079"
    ],
    "spl_id": [
     "3af0bc84-13d6-46aa-a4c0-c62410b73bc6"
    ],
    "spl_set_id": [
     "f5a860f3-37ec-429c-ae04-9c88d7c55c08"
    ],
    "package_ndc": [
     "0002-7640-01",
     "0002-7623-01"
    ],
    "unii": [
     "9T47E4OM16"
    ]
   },
   "update_date": "10/16/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  }
 ]
}